Patritumab Deruxtecan Shows Therapeutic Potential Across Multiple Breast Cancer Subtypes
A scientific review highlights clinical and preclinical evidence supporting patritumab deruxtecan as an emerging HER3-targeted therapy across diverse breast cancer ...
